Cas:1196153-93-1 4-bromo-2-chloro-6-(trifluoromethyl)pyridine manufacturer & supplier

We serve Chemical Name:4-bromo-2-chloro-6-(trifluoromethyl)pyridine CAS:1196153-93-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-bromo-2-chloro-6-(trifluoromethyl)pyridine

Chemical Name:4-bromo-2-chloro-6-(trifluoromethyl)pyridine
CAS.NO:1196153-93-1
Synonyms:4-bromo-2-chloro-6-(trifluoromethyl)pyridine
Molecular Formula:C6H2BrClF3N
Molecular Weight:260.43900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:12.89000
Exact Mass:258.90100
LogP:3.51630

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-bromo-2-chloro-6-(trifluoromethyl)pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-bromo-2-chloro-6-(trifluoromethyl)pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-bromo-2-chloro-6-(trifluoromethyl)pyridine Use and application,4-bromo-2-chloro-6-(trifluoromethyl)pyridine technical grade,usp/ep/jp grade.


Related News: The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. 4-bromo-2-chloro-6-(trifluoromethyl)pyridine manufacturer According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017). 4-bromo-2-chloro-6-(trifluoromethyl)pyridine supplier From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend. 4-bromo-2-chloro-6-(trifluoromethyl)pyridine vendor In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation. 4-bromo-2-chloro-6-(trifluoromethyl)pyridine factory Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.